Ticker LaunchSPAC · Merger completed
Summit Healthcare Acquisition Corp.
Business combination with YS Biopharma
Summit Healthcare Acquisition Corp. is a blank-check company (SPAC) that raised $200M in its initial public offering on Jun 10, 2021, listing on Nasdaq Capital Market. It completed its business combination with YS Biopharma on Mar 16, 2023; the combined company is YS Biopharma Co., Ltd. (YS). BofA Securities led the IPO, with Futu. Kirkland & Ellis advised the SPAC and Davis Polk advised the underwriters on the IPO.
- Status
- Merger completed
- IPO date
- Jun 10, 2021
- IPO size
- $200M
- IPO exchange
- Nasdaq Capital Market
- Target
- YS Biopharma (YS Biotech)
- Announced
- Sep 29, 2022
- Closed
- Mar 16, 2023
- Combined company
- YS Biopharma Co., Ltd. (YS)
- IPO underwriters
- BofA Securities and Futu
- SPAC counsel (IPO)
- Kirkland & Ellis and Maples and Calder
- Underwriters' counsel (IPO)
- Davis Polk
More on this SPAC for subscribers
- Trust balance and value per share
- Redemptions at each extension and at the merger vote
- Liquidation deadline and extension history
- Merger proxy, registration statement and investor presentation
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- IPO prospectus (424B4) Jun 10, 2021
- Deal announcement (8-K) Sep 29, 2022
- All filings on EDGAR CIK 1839185
Other deSPACs that closed in 2023
- Near Intelligence, Inc.via KludeIn I Acquisition Corp · closed Mar 23, 2023
- Zura Bio Limitedvia JATT Acquisition Corp · closed Mar 20, 2023
- NioCorp Developments Ltd.via GX Acquisition Corp. II · closed Mar 17, 2023
- CXApp Inc.via KINS Technology Group Inc. · closed Mar 14, 2023
- Oculis Holding AGvia European Biotech Acquisition Corp. · closed Mar 8, 2023
- SMX (Security Matters) Public Limited Companyvia Lionheart III Corp · closed Mar 7, 2023